{
    "ticker": "ITOS",
    "name": "ITOS Medical, Inc.",
    "description": "ITOS Medical, Inc. is a biopharmaceutical company dedicated to the development and commercialization of advanced therapeutics for patients with serious diseases. Founded in 2015, ITOS focuses on innovative treatments that leverage cutting-edge science and technology to improve patient outcomes. The company's lead product candidates are designed to address unmet medical needs in oncology and autoimmune disorders, using proprietary platforms that enhance drug efficacy and safety. ITOS is committed to rigorous clinical research and development, ensuring that its therapies undergo thorough testing to meet the highest standards of regulatory approval. With a team of experienced professionals and a robust pipeline of product candidates, ITOS aims to deliver transformational therapies that enhance the quality of life for patients around the world. The company\u2019s mission is to bring hope to patients and their families by providing access to effective and safe treatments, thereby contributing to the advancement of healthcare and the improvement of global health standards.",
    "industry": [
        "Biopharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2015",
    "website": "https://www.itosmedical.com",
    "ceo": "Dr. John Smith",
    "social_media": {
        "twitter": "https://twitter.com/ITOSMedical",
        "linkedin": "https://www.linkedin.com/company/itos-medical/"
    },
    "investor_relations": "https://ir.itosmedical.com",
    "key_executives": [
        {
            "name": "Dr. John Smith",
            "position": "CEO"
        },
        {
            "name": "Jane Doe",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Oncology Treatments",
            "products": [
                "ITO-101",
                "ITO-202"
            ]
        },
        {
            "category": "Autoimmune Therapies",
            "products": [
                "ITO-303"
            ]
        }
    ],
    "seo": {
        "meta_title": "ITOS Medical, Inc. | Innovative Biopharmaceutical Solutions",
        "meta_description": "Explore ITOS Medical, Inc., a leading biopharmaceutical company focused on developing innovative therapies for serious diseases. Learn about our mission and product pipeline.",
        "keywords": [
            "ITOS Medical",
            "Biopharmaceuticals",
            "Innovative Therapies",
            "Oncology",
            "Autoimmune Disorders"
        ]
    },
    "faq": [
        {
            "question": "What does ITOS Medical specialize in?",
            "answer": "ITOS Medical specializes in developing biopharmaceutical treatments for oncology and autoimmune disorders."
        },
        {
            "question": "Who is the CEO of ITOS Medical?",
            "answer": "The CEO of ITOS Medical is Dr. John Smith."
        },
        {
            "question": "Where is ITOS Medical headquartered?",
            "answer": "ITOS Medical is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are some of ITOS Medical's products?",
            "answer": "Some of ITOS Medical's product candidates include ITO-101, ITO-202, and ITO-303."
        },
        {
            "question": "When was ITOS Medical founded?",
            "answer": "ITOS Medical was founded in 2015."
        }
    ],
    "competitors": [
        "AMGN",
        "GILD",
        "BMY",
        "NVS"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRK",
        "ABBV"
    ]
}